nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0344	0.0349	CcSEcCtD
Oxaprozin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0255	0.0258	CcSEcCtD
Oxaprozin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.0249	0.0253	CcSEcCtD
Oxaprozin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0242	0.0245	CcSEcCtD
Oxaprozin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0226	0.0229	CcSEcCtD
Oxaprozin—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.021	0.0213	CcSEcCtD
Oxaprozin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.021	0.0213	CcSEcCtD
Oxaprozin—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.0208	0.0211	CcSEcCtD
Oxaprozin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.02	0.0202	CcSEcCtD
Oxaprozin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0196	0.0198	CcSEcCtD
Oxaprozin—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.0193	CcSEcCtD
Oxaprozin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0187	0.0189	CcSEcCtD
Oxaprozin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0187	0.0189	CcSEcCtD
Oxaprozin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0186	0.0188	CcSEcCtD
Oxaprozin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0175	0.0178	CcSEcCtD
Oxaprozin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0173	0.0176	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0175	CcSEcCtD
Oxaprozin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0173	CcSEcCtD
Oxaprozin—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0155	CcSEcCtD
Oxaprozin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.015	CcSEcCtD
Oxaprozin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0143	CcSEcCtD
Oxaprozin—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0143	CcSEcCtD
Oxaprozin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0137	CcSEcCtD
Oxaprozin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.0132	CcSEcCtD
Oxaprozin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0131	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0129	CcSEcCtD
Oxaprozin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0128	CcSEcCtD
Oxaprozin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0128	CcSEcCtD
Oxaprozin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0127	CcSEcCtD
Oxaprozin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0127	CcSEcCtD
Oxaprozin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0127	CcSEcCtD
Oxaprozin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0124	CcSEcCtD
Oxaprozin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0122	CcSEcCtD
Oxaprozin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0118	CcSEcCtD
Oxaprozin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0117	CcSEcCtD
Oxaprozin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0117	CcSEcCtD
Oxaprozin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0109	CcSEcCtD
Oxaprozin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0105	CcSEcCtD
Oxaprozin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0103	CcSEcCtD
Oxaprozin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.0099	0.01	CcSEcCtD
Oxaprozin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00986	0.01	CcSEcCtD
Oxaprozin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00984	0.00998	CcSEcCtD
Oxaprozin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00976	0.0099	CcSEcCtD
Oxaprozin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00947	0.00961	CcSEcCtD
Oxaprozin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00942	0.00955	CcSEcCtD
Oxaprozin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00932	0.00946	CcSEcCtD
Oxaprozin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00929	0.00942	CcSEcCtD
Oxaprozin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00918	0.00932	CcSEcCtD
Oxaprozin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00906	0.00919	CcSEcCtD
Oxaprozin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00903	0.00916	CcSEcCtD
Oxaprozin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.009	0.00913	CcSEcCtD
Oxaprozin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.00883	CcSEcCtD
Oxaprozin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00868	0.0088	CcSEcCtD
Oxaprozin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00853	0.00865	CcSEcCtD
Oxaprozin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00845	0.00858	CcSEcCtD
Oxaprozin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00837	0.00849	CcSEcCtD
Oxaprozin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00827	0.00839	CcSEcCtD
Oxaprozin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.00832	CcSEcCtD
Oxaprozin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.00832	CcSEcCtD
Oxaprozin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00815	0.00827	CcSEcCtD
Oxaprozin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00803	0.00815	CcSEcCtD
Oxaprozin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00793	0.00804	CcSEcCtD
Oxaprozin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00782	0.00793	CcSEcCtD
Oxaprozin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00742	0.00753	CcSEcCtD
Oxaprozin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00737	0.00747	CcSEcCtD
Oxaprozin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00731	0.00742	CcSEcCtD
Oxaprozin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.0074	CcSEcCtD
Oxaprozin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00722	0.00732	CcSEcCtD
Oxaprozin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00713	0.00723	CcSEcCtD
Oxaprozin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00701	0.00712	CcSEcCtD
Oxaprozin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00676	0.00686	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00671	0.0068	CcSEcCtD
Oxaprozin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.00661	CcSEcCtD
Oxaprozin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.00658	CcSEcCtD
Oxaprozin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.00658	CcSEcCtD
Oxaprozin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00597	CcSEcCtD
Oxaprozin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.00589	CcSEcCtD
Oxaprozin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00569	CcSEcCtD
Oxaprozin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.0055	CcSEcCtD
Oxaprozin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00522	0.00529	CcSEcCtD
Oxaprozin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00525	CcSEcCtD
Oxaprozin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00524	CcSEcCtD
Oxaprozin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00521	CcSEcCtD
Oxaprozin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00494	CcSEcCtD
Oxaprozin—Phenprocoumon—ALB—focal segmental glomerulosclerosis	0.00432	0.304	CrCbGaD
Oxaprozin—Warfarin—ALB—focal segmental glomerulosclerosis	0.00383	0.27	CrCbGaD
Oxaprozin—Flurbiprofen—ALB—focal segmental glomerulosclerosis	0.00327	0.23	CrCbGaD
Oxaprozin—Phenytoin—ALB—focal segmental glomerulosclerosis	0.00278	0.196	CrCbGaD
